The TP53 website: An integrative resource centre for the TP53 mutation database and TP53 mutant analysis

Nucleic Acids Research

Volumn 41, Issue D1, 2013, Pages

  Leroy, Bernard ^a   Fournier, Jean Louis ^a   Ishioka, Chikashi ^b   Monti, Paola ^c   Inga, Alberto ^d   Fronza, Gilberto ^c   Soussi, Thierry ^a,e  

^a SORBONNE UNIVERSITÉ   (France)

^b TOHOKU UNIVERSITY   (Japan)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF TRENTO   (Italy)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; COMPUTER INTERFACE; COMPUTER PROGRAM; COMPUTER SYSTEM; FRAMESHIFT MUTATION; GAIN OF FUNCTION MUTATION; GENETIC ALGORITHM; GENETIC DATABASE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROMOTER REGION; QUALITY CONTROL; TP53 MUTATION DATABASE; TRANSACTIVATION;

DATABASES, NUCLEIC ACID; GENES, P53; HUMANS; INTERNET; MUTATION; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84876570838     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks1033     Document Type: Article

References (37)

1. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
2. Soussi, T. (2011) Advances in carcinogenesis: a historical perspective from observational studies to tumor genome sequencing and TP53 mutation spectrum analysis. Biochim. Biophys. Acta, 1816, 199-208.
3. Soussi, T. (2011) TP53 Mutations in human cancer: database reassessment and prospects for the next decade. Adv. Cancer Res., 110, 107-139.
4. Brown, C.J., Lain, S., Verma, C.S., Fersht, A.R. and Lane, D.P. (2009) Awakening guardian angels: drugging the p53 pathway. Nat. Rev. Cancer, 9, 862-873.
5. Caron de Fromentel, C. and Soussi, T. (1992) TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer, 4, 1-15.
6. Cariello, N.F., Beroud, C. and Soussi, T. (1994) Database and software for the analysis of mutations at the human p53 gene. Nucleic Acids Res., 22, 3549-3550.
7. Beroud, C., Verdier, F. and Soussi, T. (1996) p53 gene mutation: software and database. Nucleic Acids Res., 24, 147-150.
8. Beroud, C. and Soussi, T. (1997) p53 and APC gene mutations: software and databases. Nucleic Acids Res., 25, 138.
9. Soussi, T., Dehouche, K. and Beroud, C. (2000) p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis. Hum. Mutat., 15, 105-113.
10. Beroud, C. and Soussi, T. (2003) The UMD-p53 database: new mutations and analysis tools. Hum. Mutat., 21, 176-181.
11. Hamroun, D., Kato, S., Ishioka, C., Claustres, M., Beroud, C. and Soussi, T. (2006) The UMD TP53 database and website: update and revisions. Hum. Mutat., 27, 14-20.
12. Beroud, C. and Soussi, T. (1998) p53 gene mutation: software and database. Nucleic Acids Res., 26, 200-204.
13. Edlund, K., Larsson, O., Ameur, A., Bunikis, I., Gyllensten, U., Leroy, B., Sundstrom, M., Micke, P., Botling, J. and Soussi, T. (2012) Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors. Proc. Natl Acad. Sci. USA, 109, 9551-9556.
14. Kern, S.E. and Winter, J.M. (2006) Elegance, silence and nonsense in the mutations literature for solid tumors. Cancer Biol. Ther., 5, 349-359.
15. Quach, N., Goodman, M.F. and Shibata, D. (2004) In vitro mutation artifacts after formalin fixation and error prone translesion synthesis during PCR. BMC Clin. Pathol., 4, 1.
16. Soussi, T. and Beroud, C. (2001) Assessing TP53 status in human tumours to evaluate clinical outcome. Nat. Rev. Cancer, 1, 233-240.
17. Kato, S., Han, S.Y., Liu, W., Otsuka, K., Shibata, H., Kanamaru, R. and Ishioka, C. (2003) Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc. Natl Acad. Sci. USA, 100, 8424-8429.
18. Soussi, T., Asselain, B., Hamroun, D., Kato, S., Ishioka, C., Claustres, M. and Beroud, C. (2006) Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection. Clin. Cancer Res., 12, 62-69.
19. Soussi, T., Kato, S., Levy, P.P. and Ishioka, C. (2005) Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Hum. Mutat., 25, 6-17.
20. Soussi, T., Ishioka, C., Claustres, M. and Beroud, C. (2006) Locus-specific mutation databases: pitfalls and good practice based on the p53 experience. Nat. Rev. Cancer, 6, 83-90.
21. Berglind, H., Pawitan, Y., Kato, S., Ishioka, C. and Soussi, T. (2008) Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination. Cancer Biol. Ther., 7, 699-708.
22. Ikediobi, O.N., Davies, H., Bignell, G., Edkins, S., Stevens, C., O'Meara, S., Santarius, T., Avis, T., Barthorpe, S., Brackenbury, L. et al. (2006) Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol. Cancer Ther., 5, 2606-2612.
23. den Dunnen, J.T. and Antonarakis, S.E. (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum. Mutat., 15, 7-12.
24. Harris, S.L. and Levine, A.J. (2005) The p53 pathway: positive and negative feedback loops. Oncogene, 24, 2899-2908.
25. Levine, A.J. (2011) Introduction: the changing directions of p53 research. Genes Cancer, 2, 382-384.
26. Lane, D. and Levine, A. (2010) P53 research: the past thirty years and the next thirty years. Cold Spring Harb. Perspect. Biol., 2, a000893.
27. Monti, P., Ciribilli, Y., Jordan, J., Menichini, P., Umbach, D.M., Resnick, M.A., Luzzatto, L., Inga, A. and Fronza, G. (2007) Transcriptional functionality of germ line p53 mutants influences cancer phenotype. Clin. Cancer Res., 13, 3789-3795.
28. Oren, M. and Rotter, V. (2010) Mutant p53 gain-of-function in cancer. Cold Spring Harb. Perspect. Biol., 2, a001107.
29. Robles, A.I. and Harris, C.C. (2010) Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb. Perspect. Biol., 2, a001016.
30. Yu, X., Vazquez, A., Levine, A.J. and Carpizo, D.R. (2012) Allele-specific p53 mutant reactivation. Cancer Cell, 21, 614-625.
31. Boeckler, F.M., Joerger, A.C., Jaggi, G., Rutherford, T.J., Veprintsev, D.B. and Fersht, A.R. (2008) Targeted rescue of a destabilized mutant of p53 by an in silico screened drug. Proc. Natl Acad. Sci. USA, 105, 10360-10365.
32. Ng, P.C. and Henikoff, S. (2006) Predicting the effects of amino acid substitutions on protein function. Annu. Rev. Genomics Hum. Genet., 7, 61-80.
33. Jackson, J.G., Pant, V., Li, Q., Chang, L.L., Quintas-Cardama, A., Garza, D., Tavana, O., Yang, P., Manshouri, T., Li, Y. et al. (2012) p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell, 21, 793-806.
34. de Cremoux, P., Salomon, A.V., Liva, S., Dendale, R., Bouchind'homme, B., Martin, E., Sastre-Garau, X., Magdelenat, H., Fourquet, A. and Soussi, T. (1999) p53 mutation as a genetic trait of typical medullary breast carcinoma. J. Natl Cancer Inst., 91, 641-643.
35. Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R. and Gu, W. (2012) Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell, 149, 1269-1283.
36. Brady, C.A., Jiang, D., Mello, S.S., Johnson, T.M., Jarvis, L.A., Kozak, M.M., Kenzelmann Broz, D., Basak, S., Park, E.J., McLaughlin, M.E. et al. (2011) Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell, 145, 571-583.
37. Chin, L., Hahn, W.C., Getz, G. and Meyerson, M. (2011) Making sense of cancer genomic data. Genes Dev., 25, 534-555.